Guidance in author instructions of hematology and oncology journals: A cross sectional and longitudinal study

PLoS ONE

Volumn 12, Issue 4, 2017, Pages

  Toews, Ingrid ^a   Binder, Nadine ^b   Wolff, Robert F ^c   Toprak, Guenes ^a   Von Elm, Erik ^d   Meerpohl, Joerg J ^a,e  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

^c KLEIJNEN SYSTEMATIC REVIEWS LTD   (United Kingdom)

^d UNIVERSITY OF LAUSANNE   (Switzerland)

^e PARIS DESCARTES UNIVERSITY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CASE REPORT; CONFLICT OF INTEREST; DATA EXTRACTION; EDITOR; HEMATOLOGY; HUMAN; JOURNAL IMPACT FACTOR; LOGISTIC REGRESSION ANALYSIS; LONGITUDINAL STUDY; MEDICAL LITERATURE; MOOSE; NONHUMAN; ONCOLOGY; PRACTICE GUIDELINE; REGISTRATION; STATISTICAL MODEL; CROSS-SECTIONAL STUDY; NEOPLASM; PUBLICATION; TIME FACTOR; TRANSLATIONAL RESEARCH; WRITING;

AUTHORSHIP; CROSS-SECTIONAL STUDIES; HEMATOLOGY; HUMANS; JOURNAL IMPACT FACTOR; LONGITUDINAL STUDIES; NEOPLASMS; PERIODICALS AS TOPIC; TIME FACTORS; TRANSLATIONAL MEDICAL RESEARCH;

EID: 85018372732     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0176489     Document Type: Article

References (58)

1. Dancey JE. From quality of publication to quality of care: translating trials to practice. J Natl Cancer Inst. 2010; 102(10):670-1. Epub 2010 Apr 21. https://doi.org/10.1093/jnci/djq142 PMID: 20410467
2. Duff JM, Leather H, Walden EO, LaPlant KD, George TJ Jr. Adequacy of published oncology randomized controlled trials to provide therapeutic details needed for clinical application. J Natl Cancer Inst. 2010; 102(10):702-5. Epub 2010 Apr 21. https://doi.org/10.1093/jnci/djq117 PMID: 20410466
3. Ioannidis JP. Adverse events in randomized trials: neglected, restricted, distorted, and silenced. Arch Intern Med. 2009; 169(19):1737-9. https://doi.org/10.1001/archinternmed.2009.313 PMID: 19858427
4. Pitrou I, Boutron I, Ahmad N, Ravaud P. Reporting of safety results in published reports of randomized controlled trials. Arch Intern Med. 2009; 169(19):1756-61. https://doi.org/10.1001/archinternmed.2009.306 PMID: 19858432
5. Sinha S, Ashby E, Jayaram R, Grocott MP. Quality of reporting in randomized trials published in highquality surgical journals. J Am Coll Surg. 2009; 209(5):565-71 e1. Epub 2009/10/27. https://doi.org/10. 1016/j.jamcollsurg.2009.07.019 PMID: 19854395
6. Bekelman JE, Li Y, Gross CP. Scope and impact of financial conflicts of interest in biomedical research: a systematic review. Jama. 2003; 289(4):454-65. PMID: 12533125
7. Lexchin J, Bero LA, Djulbegovic B, Clark O. Pharmaceutical industry sponsorship and research outcome and quality: systematic review. BMJ. 2003; 326(7400):1167-70. https://doi.org/10.1136/bmj.326. 7400.1167 PMID: 12775614
8. Glasziou P, Altman DG, Bossuyt P, Boutron I, Clarke M, Julious S, et al. Reducing waste from incomplete or unusable reports of biomedical research. Lancet (London, England). 2014; 383(9913):267-76.
9. Ioannidis JPA, Greenland S, Hlatky MA, Khoury MJ, Macleod MR, Moher D, et al. Increasing value and reducing waste in research design, conduct, and analysis. Lancet (London, England). 2014; 383 (9912):166-75.
10. International Committee of Medical Journal Editors. Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly work in Medical Journals 2015 [cited 2015 23 December 2015]. http://www.icmje.org/recommendations/.
11. Plint AC, Moher D, Morrison A, Schulz K, Altman DG, Hill C, et al. Does the CONSORT checklist improve the quality of reports of randomised controlled trials? A systematic review. The Medical journal of Australia. 2006; 185(5):263-7. Epub 2006/09/05. PMID: 16948622
12. Tao K-m, Li X-q, Zhou Q-h, Moher D, Ling C-q, Yu W-f. From QUOROM to PRISMA: A Survey of High-Impact Medical Journals' Instructions to Authors and a Review of Systematic Reviews in Anesthesia Literature. PLoS ONE. 2011; 6(11):e27611. https://doi.org/10.1371/journal.pone.0027611 PMID: 22110690
13. Altman DG. Endorsement of the CONSORT statement by high impact medical journals: survey of instructions for authors. BMJ. 2005; 330(7499):1056-7. Epub 2005/05/10. https://doi.org/10.1136/bmj. 330.7499.1056 PMID: 15879389
14. Hopewell S, Altman DG, Moher D, Schulz KF. Endorsement of the CONSORT Statement by high impact factor medical journals: a survey of journal editors and journal 'Instructions to Authors'. Trials. 2008; 9(1):20.
15. Li X-q, Tao K-m, Zhou Q-h, Moher D, Chen H-y, Wang F-z, et al. Endorsement of the CONSORT Statement by High-Impact Medical Journals in China: A Survey of Instructions for Authors and Published Papers. PLoS ONE. 2012; 7(2):e30683. https://doi.org/10.1371/journal.pone.0030683 PMID: 22348017
16. McLeroy KR, Northridge ME, Balcazar H, Greenberg MR, Landers SJ. Reporting Guidelines and the American Journal of Public Health's Adoption of Preferred Reporting Items for Systematic Reviews and Meta-Analyses. Am J Public Health. 2012; 102(5):780-4. https://doi.org/10.2105/AJPH.2011.300630PMID: 22420806
17. Schriger DL, Arora S, Altman DG. The Content of Medical Journal Instructions for Authors. Ann Emerg Med. 2006; 48(6):743-9.e4. https://doi.org/10.1016/j.annemergmed.2006.03.028 PMID: 17112938
18. Smidt N, Overbeke J, de Vet H, Bossuyt P. Endorsement of the STARD Statement by biomedical journals: survey of instructions for authors. Clinical chemistry. 2007; 53(11):1983-5. Epub 2007/10/24. https://doi.org/10.1373/clinchem.2007.090167 PMID: 17954503
19. Meerpohl JJ, Wolff RF, Niemeyer CM, Antes G, von Elm E. Editorial policies of pediatric journals: survey of instructions for authors. Archives of pediatrics & adolescent medicine. 2010; 164(3):268-72. Epub 2010/03/03.
20. Meerpohl JJ, Wolff RF, Antes G, von Elm E. Are pediatric Open Access journals promoting good publication practice? An analysis of author instructions. BMC pediatrics. 2011; 11:27. Epub 2011/04/12. https://doi.org/10.1186/1471-2431-11-27 PMID: 21477335
21. Knüppel H, Metz C, Meerpohl JJ, Strech D. How Psychiatry Journals Support the Unbiased Translation of Clinical Research. A Cross-Sectional Study of Editorial Policies. PLoS ONE. 2013; 8(10):e75995. https://doi.org/10.1371/journal.pone.0075995 PMID: 24146806
22. Pellizzon Rde F, Montero EF, Poblacion DA, Monteiro R, Castro RC. Brazilian scientific journals in surgery. III: Analysis of the instructions for authors based on Vancouver uniform requirements. Acta cirurgica brasileira / Sociedade Brasileira para Desenvolvimento Pesquisa em Cirurgia. 2007; 22(6):503-17. Epub 2008/02/01.
23. Reveiz L, Villanueva E, Iko C, Simera I. Compliance with clinical trial registration and reporting guidelines by Latin American and Caribbean journals. Cadernos de saude publica. 2013; 29(6):1095-100.Epub 2013/06/20. PMID: 23778541
24. Shantikumar S, Wigley J, Hameed W, Handa A. A survey of instructions to authors in surgical journals on reporting by CONSORT and PRISMA. Ann R Coll Surg Engl. 2012; 94(7):468-71.
25. Smith TA, Kulatilake P, Brown LJ, Wigley J, Hameed W, Shantikumar S. Do surgery journals insist on reporting by CONSORT and PRISMA? A follow-up survey of 'instructions to authors'. Ann Med Surg. 2015; 4(1):17-21.
26. Sim I, Chan AW, Gulmezoglu AM, Evans T, Pang T. Clinical trial registration: transparency is the watchword. Lancet. 2006; 367(9523):1631-3. Epub 2006/05/23. https://doi.org/10.1016/S0140-6736(06) 68708-4 PMID: 16714166
27. You B, Gan HK, Pond G, Chen EX. Consistency in the Analysis and Reporting of Primary End Points in Oncology Randomized Controlled Trials From Registration to Publication: A Systematic Review. J Clin Oncol. 2012; 30(2):210-6. https://doi.org/10.1200/JCO.2011.37.0890 PMID: 22162583
28. Dwan K, Altman DG, Arnaiz JA, Bloom J, Chan AW, Cronin E, et al. Systematic review of the empirical evidence of study publication bias and outcome reporting bias. PLoS ONE. 2008; 3(8):e3081. Epub 2008/09/05. https://doi.org/10.1371/journal.pone.0003081 PMID: 18769481
29. Smith R. Beyond conflict of interest. Transparency is the key. BMJ. 1998; 317(7154):291-2. PMID: 9685268
30. Bhargava N, Qureshi J, Vakil N. Funding source and conflict of interest disclosures by authors and editors in gastroenterology specialty journals. Am J Gastroenterol. 2007; 102(6):1146-50. Epub 2007/05/29 https://doi.org/10.1111/j.1572-0241.2007.01268.x PMID: 17531007
31. Lundh A, Sismondo S, Lexchin J, Busuioc Octavian A, Bero L. Industry sponsorship and research outcome. Cochrane Database Syst Rev [Internet]. 2012; (12).
32. Kesselheim AS, Lee JL, Avorn J, Servi A, Shrank WH, Choudhry NK. Conflict of interest in oncology publications. Cancer. 2012; 118(1):188-95. https://doi.org/10.1002/cncr.26237 PMID: 21717432
33. Journal Citation Report 2014 [Internet]. 2014. www.webofknowledge.com.
34. Schulz KF, Altman DG, Moher D. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. PLoS Med. 2010; 7(3):e1000251. Epub 2010/03/31. https://doi.org/10.1371/ journal.pmed.1000251 PMID: 20352064
35. Moher D, Hopewell S, Schulz KF, Montori V, Gotzsche PC, Devereaux PJ, et al. CONSORT 2010 Explanation and Elaboration: Updated guidelines for reporting parallel group randomised trials. J Clin Epidemiol. 2010; 63(8):e1-37. Epub 2010/03/30. https://doi.org/10.1016/j.jclinepi.2010.03.004 PMID: 20346624
36. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. Jama. 2000; 283(15):2008-12. PMID: 10789670
37. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and metaanalyses: the PRISMA statement. BMJ. 2009; 339:b2535. Epub 2009/07/23. https://doi.org/10.1136/ bmj.b2535 PMID: 19622551
38. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009; 339:b2700. Epub 2009/07/23. https://doi.org/10.1136/bmj. b2700 PMID: 19622552
39. Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig LM, et al. The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration. AnnInternMed. 2003; 138(1): W1-12.
40. Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig LM, et al. Towards complete and accurate reporting of studies of diagnostic accuracy: The STARD Initiative. AnnInternMed. 2003; 138 (1):40-4.
41. Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig L, et al. STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies. BMJ. 2015; 351.
42. von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Ann Intern Med. 2007; 147(8):573-7. Epub 2007/10/17. PMID: 17938396
43. Vandenbroucke JP, von Elm E, Altman DG, Gotzsche PC, Mulrow CD, Pocock SJ, et al. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. Ann Intern Med. 2007; 147(8):W163-94. Epub 2007/10/17. PMID: 17938389
44. McGinn T, Wyer PC, Newman TB, Keitz S, Leipzig R, For GG. Tips for learners of evidence-based medicine:3. Measures of observer variability (kappa statistic). CMAJ: Canadian Medical Association journal = journal de l'Association medicale canadienne. 2004; 171(11):1369-73. Epub 2004/11/24. https://doi. org/10.1503/cmaj.1031981 PMID: 15557592
45. Brown H, Prescott R. Statistics in Practice. Applied Mixed Models in Medicine: John Wiley & Sons, Ltd;2006. p. 456-7.
46. R Development Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria (http://wwwR-projectorg/). 2011.
47. Kesselheim AS, Lee JL, Avorn J, Servi A, Shrank WH, Choudhry NK. Conflict of interest in oncology publications: A survey of disclosure policies and statements. Cancer. 2011. Epub 2011/07/01.
48. Hernan MA. Impact factor: a call to reason. Epidemiology. 2009; 20(3):317-8; discussion 9-20. Epub 2009/04/14. https://doi.org/10.1097/EDE.0b013e31819ed4a6 PMID: 19363351
49. Ancker JS, Flanagin A. A comparison of conflict of interest policies at peer-reviewed journals in different scientific disciplines. Science and engineering ethics. 2007; 13(2):147-57. Epub 2007/08/25. https:// doi.org/10.1007/s11948-007-9011-z PMID: 17717729
50. Altman DG. Endorsement of the CONSORT statement by high impact medical journals: survey of instructions for authors. BMJ. 2005; 330(7499):1056-7. https://doi.org/10.1136/bmj.330.7499.1056PMID: 15879389
51. Kunath F, Grobe HR, Keck B, Rucker G, Wullich B, Antes G, et al. Do urology journals enforce trial registration? A cross-sectional study of published trials. BMJ Open. 2011; 1(2):e000430. Print 2011. https://doi.org/10.1136/bmjopen-2011-000430 PMID: 22146890
52. Kunath F, Grobe HR, Rucker G, Engehausen D, Antes G, Wullich B, et al. Do journals publishing in the field of urology endorse reporting guidelines? A survey of author instructions. Urol Int. 2012; 88(1):54-9. Epub 2011 Nov 19. https://doi.org/10.1159/000332742 PMID: 22104723
53. Chan A-W, Song F, Vickers A, Jefferson T, Dickersin K, Gøtzsche PC, et al. Increasing value and reducing waste: addressing inaccessible research. Lancet (London, England). 2014; 383(9913):257-66.
54. Toulmonde M, Bellera C, Mathoulin-Pelissier S, Debled M, Bui B, Italiano A. Quality of randomized controlled trials reporting in the treatment of sarcomas. Journal of clinical oncology: official journal of the American Society of Clinical Oncology. 2011; 29(9):1204-9. Epub 2011/02/16.
55. Hui D, Arthur J, Dalal S, Bruera E. Quality of the supportive and palliative oncology literature: a focused analysis on randomized controlled trials. Supportive care in cancer: official journal of the Multinational Association of Supportive Care in Cancer. 2011. Epub 2011/09/22.
56. Kunath F, Grobe HR, Keck B, Rucker G, Wullich B, Antes G, et al. Do urology journals enforce trial registration? A cross-sectional study of published trials. BMJ Open. 2011; 1(2):e000430. Epub 2011/12/08. https://doi.org/10.1136/bmjopen-2011-000430 PMID: 22146890
57. Altman DG, Moher D. Declaration of transparency for each research article. BMJ. 2013; 347.
58. Blum JA, Freeman K, Dart RC, Cooper RJ. Requirements and definitions in conflict of interest policies of medical journals. Jama. 2009; 302(20):2230-4. Epub 2009/11/26. https://doi.org/10.1001/jama. 2009.1669 PMID: 19934424